IA

Immunotargets And Therapy

ImmunoTargets and Therapy is an international open access journal that publishes basic and clinical research on immunology in health and disease, with a focus on the biology of the immune system, immune-based therapies, the immunological basis of disease, and the evidence behind new and existing immunotherapies. Specific topics include immune system biology and pathophysiology, immunological markers of disease, targets for immune-based therapy, immunodiagnostics and immunomonitoring, treatment protocols for immune-mediated diseases, management programs and therapeutic agents, and patient-centered outcomes such as quality of life, adherence, and satisfaction.

Looking to publish in Immunotargets And Therapy? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.

Try Livewrite Now
Subject Immunology
Impact Factor 4.4
Quartile Q2
Open Access Type Open
eISSN 2253-1556
Invitation Only No
Cost Range An Article Publishing Charge (APC) may be required for open access publication; authors may be able to publish at no cost to themselves or with a reduced APC through institutional or funder agreements, and discounts and waivers may be available for selected countries.

Submission Instructions

Immunotargets And Therapy accepts the following article types. Click on an article type to view submission instructions.

Clinical Trial Report

Cover Letter Cover Letter requirements are not specified.
Abstract Abstract must not exceed 300 words. Abstract may be structured or unstructured.
Manuscript Manuscript must include the sections Introduction, Material and Methods, Results, Discussion, and Conclusions. Manuscript must include the clinical trial number and registration date, usually in the abstract and methods sections, and provide 3–6 keywords.
References References requirements are not specified.
Figures & Tables Figures must be provided separate from the manuscript, tables must be provided in editable format, and pasted figures or image-based tables are not allowed. All figures and tables must be cited in the text, and figure legends and table keys or explanatory notes must be included when needed to explain labels, symbols, abbreviations, or formatting.
Reformat to Immunotargets And Therapy using Livewrite Premium

Original Research

Cover Letter Cover Letter requirements are not specified.
Abstract Abstract is required for Original Research. Abstract must not exceed 300 words. Abstract must be structured.
Manuscript Manuscript typically includes Abstract, Introduction, Methods, Results, Discussion, and Conclusion sections. Manuscript must include 3–6 keywords.
References References requirements are not specified.
Figures & Tables Figures must be provided separate from the manuscript, and tables must be provided in an editable format rather than as images. Figures and tables must each be cited in the text, with figure legends and table legends or footnotes providing explanatory keys when needed.
Reformat to Immunotargets And Therapy using Livewrite Premium

Registered Report

Cover Letter Cover Letter requirements are not specified.
Abstract Abstract must not exceed 300 words.
Manuscript Manuscript must include the sections Introduction, Material and Methods, Results, Discussion, and Conclusions. Manuscript must include 3–6 keywords.
References References requirements are not specified.
Figures & Tables Figures must be provided separate from the manuscript, and tables must be provided in their original editable format rather than as images. All figures and tables must be cited in the text, figures must not be pasted into the manuscript, and tables must not be supplied as images.
Reformat to Immunotargets And Therapy using Livewrite Premium

Review

Cover Letter Cover Letter requirements are not specified.
Abstract Abstract must not exceed 300 words.
Manuscript Manuscript must include the sections Introduction, Material and Methods, Results, Discussion, and Conclusions. Manuscript must include 3–6 keywords.
References References requirements are not specified.
Figures & Tables Figures must be provided separate from the manuscript, and tables must be provided in their original editable format rather than as images. Figures and tables must be cited in the text, and figure legends and table legends must include explanatory keys or notes when symbols, abbreviations, or formatting indicate significant data.
Reformat to Immunotargets And Therapy using Livewrite Premium

Case Report

Cover Letter Cover Letter requirements are not specified.
Abstract Abstract must not exceed 300 words. Abstract may be structured or unstructured.
Manuscript Manuscript must include the sections Introduction, Material and Methods, Results, Discussion, and Conclusions. Manuscript must include 3–6 keywords.
References References requirements are not specified.
Figures & Tables Figures must be uploaded separately from the manuscript, and tables must be provided in their original editable format. Figures must not be pasted into the manuscript, and tables must not be supplied as images.
Reformat to Immunotargets And Therapy using Livewrite Premium

Case Series

Cover Letter Cover Letter requirements are not specified.
Abstract An abstract is required and must not exceed 300 words. Abstract must be no more than 300 words.
Manuscript Manuscript must include the sections Introduction, Material and Methods, Results, Discussion, and Conclusions. Manuscript must include 3–6 keywords.
References References requirements are not specified.
Figures & Tables Figures must be provided separate from the manuscript, and tables must be provided in an editable format rather than as images. Figures and tables must each be cited in the text, and table legends must appear above each table while figure legends begin with the figure number.
Reformat to Immunotargets And Therapy using Livewrite Premium

Letter To The Editor

Cover Letter Cover Letter requirements are not specified.
Abstract Abstract requirements are not specified.
Manuscript Letters To The Editor are limited to 1500 words.
References Letters To The Editor must contain no more than 15 references, including one reference to the article under discussion.
Figures & Tables Letters To The Editor must not contain figures or tables.
Reformat to Immunotargets And Therapy using Livewrite Premium

Rapid Communication

Cover Letter Cover Letter requirements are not specified.
Abstract Abstract must not exceed 300 words.
Manuscript Rapid Communication manuscripts must be up to 2000 words. Manuscript must include the sections Introduction, Material and Methods, Results, Discussion, and Conclusions. Manuscript must include 3–6 keywords.
References References requirements are not specified.
Figures & Tables Figures must be provided separately from the manuscript, and tables must be provided in an editable format rather than as images.
Reformat to Immunotargets And Therapy using Livewrite Premium

Research Letter

Cover Letter Cover Letter requirements are not specified.
Abstract Abstract must not be included.
Manuscript Research Letter text must not exceed 2,000 words. Manuscript must include the sections Introduction, Material and Methods, Results, Discussion, and Conclusions. Keywords must not be included.
References Research Letters must not exceed 7 references.
Figures & Tables Research Letters may include up to 2 tables or figures, including photographs or images. Figures must be provided separate from the manuscript, and the manuscript must not contain pasted figures.
Reformat to Immunotargets And Therapy using Livewrite Premium

Short Report

Cover Letter Cover Letter requirements are not specified.
Abstract Abstract must not exceed 300 words.
Manuscript Short Reports must be up to 2000 words. Manuscripts must include the sections Introduction, Material and Methods, Results, Discussion, and Conclusions. Manuscripts must include 3–6 keywords.
References References requirements are not specified.
Figures & Tables Figures must be provided separate from the manuscript, and tables must be provided in their original editable format rather than as images. All figures and tables must be cited in the text, with figure legends beginning with the figure number and table legends presented above each table.
Reformat to Immunotargets And Therapy using Livewrite Premium

Meeting Report

Cover Letter Cover Letter requirements are not specified.
Abstract A short unstructured abstract is required. Abstract must not exceed 300 words. Abstract must be unstructured. Abstract must state the name, location (city and state or country), dates, and nature of the meeting.
Manuscript Manuscript must not exceed 2500 words. Body may include subsections with short headings. If speakers are mentioned, each speaker’s full name, institution, city, and country must be provided, and a URL to the meeting abstract collection should be included if such a collection was published.
References Reference list must not be included.
Figures & Tables Figures must be uploaded separately from the manuscript. Figures must not be pasted into the manuscript, and tables must be supplied in editable format rather than as images.
Reformat to Immunotargets And Therapy using Livewrite Premium

Recent Publications

An Exploratory in vitro Study of Cytotoxicity and Cytokine Profiling of Cytokine-Induced Killer (CIK) Cells Against HCT-15 Colorectal Cancer (CRC) Cells

Sze-Piaw Chin, Natasha Najwa Nor Arfuzir, Vivian Wai-Ping Kong, Soon-Keng Cheong

10.2147/itt.s594441
View Publication

Development of an Active Chimeric IL13Rα2 ADC for Diffuse Intrinsic Pontine Glioma

Xiaolei Lian, Victoria Allanson, Samuel Rasmussen, Shefali Chauhan, Guak-Kim Tan, Paige Morrow, Kyle Hanson, Emily Lian, Anthony Haight, Tyuji Hoshino, Xianzhi Liu, Noah Berlow, Charles Keller, Yajun Lian

10.2147/itt.s575767
View Publication

A Review of Aryl Hydrocarbon Receptor–Mediated Immune Regulation in Cutaneous Squamous Cell Carcinoma Progression

Huiyan Han, Qinyi Dong, Zijian Zhang, Siying Li, Han Zhang, Xinman Wang, Jiahao Bai, Lei Shi, Xiaoyi Fu, Kaili Zheng, Lili Liang

10.2147/itt.s601152
View Publication

Carcinoembryonic Antigen Flare Under Oxaliplatin-Based Chemotherapy Predicts Benefit from Nivolumab in Metastatic Microsatellite-Stable Colorectal Cancer – A Post Hoc Analysis of METIMMOX Trial Data

Sebastian Meltzer, Silje Landmark, Jūratė Šaltytė Benth, Anne Negård, Hanne Mari Hamre, Christian Kersten, Eva Hofsli, Marianne Grønlie Guren, Halfdan Sorbye, Kjersti Flatmark, Anne Ree

10.2147/itt.s594176
View Publication

Role of Cytokines in Bone Diseases and Their Therapeutic Application

Adrita Guha, Praneet Wahi, Girdhari Lal

10.2147/itt.s604392
View Publication

Frequently asked questions

How long does it take to publish?

Is a cover letter required?

A point-by-point covering letter is required when submitting a revised manuscript after first editorial review.

Reformat to Immunotargets And Therapy using Livewrite Premium

What are the publication costs?

An Article Publishing Charge (APC) may be required for publication. Authors may be able to publish at no cost to themselves or with a reduced APC through institutional or funder agreements, and discounts and waivers may be available for selected countries.

Reformat to Immunotargets And Therapy using Livewrite Premium

Research Topics

Cancer Immunotherapy and Biomarkers Immunotherapy and Immune Responses Immune Cell Function and Interaction CAR-T cell therapy research Immune cells in cancer Monoclonal and Polyclonal Antibodies Research Ferroptosis and cancer prognosis Hepatocellular Carcinoma Treatment and Prognosis Immune Response and Inflammation T-cell and B-cell Immunology Lymphoma Diagnosis and Treatment Cholangiocarcinoma and Gallbladder Cancer Studies Immunodeficiency and Autoimmune Disorders Peripheral Neuropathies and Disorders Psoriasis: Treatment and Pathogenesis Dermatology and Skin Diseases Diabetes and associated disorders Chronic Lymphocytic Leukemia Research SARS-CoV-2 and COVID-19 Research Systemic Lupus Erythematosus Research Single-cell and spatial transcriptomics Autoimmune Neurological Disorders and Treatments Tuberculosis Research and Epidemiology Multiple Sclerosis Research Studies Virus-based gene therapy research